Cited by 201Transgenic Plants and ApplicationsAlgal biology and biofuel productionViral Infectious Diseases and Gene Expression in Insects

Chlamydomonas reinhardtii chloroplasts as protein factories

Mayfield, Stephen P, Manuell, Andrea L, Chen, Stephen, Wu, Joann, Tran, Miller, Siefker, David, Muto, Machiko, Marin-Navarro, Julia·2007·Current Opinion in Biotechnology

Abstract

Protein-based therapeutics are the fastest growing sector of drug development, mainly because of the high sensitivity and specificity of these molecules. Their high specificity leads to few side effects and excellent success rates in drug development. However, the inherent complexity of these molecules restricts their synthesis to living cells, making recombinant proteins expensive to produce. In addition to therapeutic uses, recombinant proteins also have a variety of industrial applications and are important research reagents. Eukaryotic algae offer the potential to produce high yields of recombinant proteins more rapidly and at much lower cost than traditional cell culture. Additionally, transgenic algae can be grown in complete containment, reducing any risk of environmental contamination. This system might also be used for the oral delivery of therapeutic proteins, as green algae are edible and do not contain endotoxins or human viral or prion contaminants.

Integrity signals

Registry

Crossref · 10.1016/j.copbio.2007.02.001

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The plastid genome of Chlamydomonas has been successfully transformed and has become a consistent method for heterologous protein expression.

    “the plastid genome of Chlamydomonas has been successfully transformed and has become a consistent method for heterologous protein expression [117,118]”

    From Biofuels from algae: Challenges and potential (2010) · cites this paper as [117]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Mayfield, S. P., Manuell, A. L., Chen, S., Wu, J., Tran, M., Siefker, D., Muto, M., & Marin-Navarro, J.
Affiliations
Scripps Research Institute (US)
Corresponding author
Mayfield, Stephen P
Venue
Current Opinion in Biotechnology
Publisher
Elsevier BV
Published
2007-04
Volume
18
Issue
2
Pages
126-133
ISSN
0958-1669 (ISSN-L)
OpenAlex
W1979062116
Cited by
201
References
53
Citations by year
2026: 4 · 2025: 4 · 2024: 8 · 2023: 12 · 2022: 7 · 2021: 6 · 2020: 10 · 2019: 5 · 2018: 11 · 2017: 14 · 2016: 13 · 2015: 14 · 2014: 15 · 2013: 19 · 2012: 21
FWCI
0.73
Type
journal article
Language
en
Open access
closed
Locations
  • Current Opinion in Biotechnology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • U.S. Department of Energy
  • National Institute of General Medical Sciences (R01GM054659)
  • National Institute of Allergy and Infectious Diseases (AI059614, R01AI059614)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Transgenic Plants and Applications
  • Physical Sciences › Energy › Renewable Energy, Sustainability and the Environment › Algal biology and biofuel production
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
Keywords
Chlamydomonas reinhardtii, chloroplasts, recombinant protein expression, therapeutic proteins, transgenic algae, algal bioreactors, industrial protein production
MeSH terms
Animals, Chloroplasts, Genetic Vectors, Recombinant Proteins, Transfection, Viruses, Protein Engineering, Chlamydomonas reinhardtii, Chlamydophila

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review